EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

P-move: a randomized control trial of exercise in patients with advanced pancreatic or biliary tract cancer (aPBC) receiving beyond first-line chemotherapy

Nico De Lazzari iD, Miriam Götte iD, Stefan Kasper, Eileen Meier, Martin Schuler, Michael Pogorzelski, Jens T Siveke iD, Mitra Tewes iD

Supportive Care in Cancer · 2024

DOI: 10.1007/s00520-024-08650-9 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Supportive Care in Cancer, 2024. Verfasst von Nico De Lazzari und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, West German Cancer Center, University Hospital Essen, 45147, Essen, Germany. Hauptthemen laut MEDLINE: Biliary Tract Neoplasms, Pancreatic Neoplasms, Exercise Therapy, Quality of Life. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Essen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Patients with advanced pancreatic and biliary tract cancer (aPBC) frequently suffer from high symptom burden. Exercise can reduce treatment side effects and improve patient-related outcomes (PROMs). However, evidence from prospective studies regarding feasibility and efficacy in advanced settings are sparse. The primary aim of this prospective, randomized-controlled study was to evaluate the feasibility and effects of exercise (ET) in patients with aPBC.

Methods

Patients with aPBC beyond first-line therapy were randomized according to the minimization procedure with stratification by gender, age, and loss of body weight in the past six months. The intervention group (IG) completed 3 training units/week for 8 weeks (1x supervised strength sessions, 2x individualized home-based sessions). Control group (CG) received recommendations on physical activity during cancer.

Results

41 patients (stage IV pancreatic or biliary tract cancer) were included no adverse events related to exercise occurred during the trial. Physical function increased significantly in IG in 5 out of 7 physical domains. Comparison of IG and CG at 8 weeks (t2) showed significant differences in favour of IG in leg press ( p =0.001), bench press ( p =0.011), sit-to-stand ( p =0.001) and crunch (0.006). Constipation revealed a significant difference in favour of IG at t2 ( p =0.033). Quality of life stabilized/increased in IG during the study period compared to a decrease in CG. Throughout/Over the 8 weeks, fatigue notably reduced in the IG ( p =0.028).

Conclusion

Exercise is safe and feasible in patients with aPBC undergoing further line therapy. Significant improvements in physical functioning and increased quality of life were achieved. German Clinical Trials Register ID: DRKS00021179; Registration date 15.05.2020

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biliary Tract NeoplasmsPancreatic NeoplasmsExercise TherapyQuality of LifeHumansMaleFemaleAgedMiddle AgedProspective StudiesFeasibility Studies

Stichwörter der Autor:innen

Cancer cachexiaPalliative chemotherapyPancreatobiliary cancerPhysical activityStrength training

Autor:innen und Institutionen

  • Department of Medical Oncology, West German Cancer Center, University Hospital Essen, 45147, Essen, Germany.
  • West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
  • Department of Palliative Medicine, West German Cancer Center, University Hospital Essen, Margot-von-Bonin-Haus, 2. Floor, Room 2.017, Hohlweg 8, 45147, Essen, Germany.
  • German Cancer Consortium (DKTK), partner site Essen, a partnership between German Cancer Research Center (DKFZ) and University Hospital Essen, 45147, Essen, Germany.
  • National Center for Tumor Diseases (NCT) West, Campus Essen, University Hospital Essen, 45147, Essen, Germany.
  • Bridge Institute of Experimental Tumor Therapy (BIT) and Division of Solid Tumor Translational Oncology (DKTK), West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, 45147, Essen, Germany.

ORCID-Profile: Nico De Lazzari, Miriam Götte, Jens T Siveke, Mitra Tewes

Förderung

  • Universitätsklinikum Essen

Zitieren

APA

De Lazzari, N., Götte, M., Kasper, S., Meier, E., Schuler, M., Pogorzelski, M., Siveke, J. T., & Tewes, M. (2024). P-move: a randomized control trial of exercise in patients with advanced pancreatic or biliary tract cancer (aPBC) receiving beyond first-line chemotherapy. Supportive Care in Cancer. https://doi.org/10.1007/s00520-024-08650-9

Vancouver

De Lazzari N, Götte M, Kasper S, Meier E, Schuler M, Pogorzelski M, et al. P-move: a randomized control trial of exercise in patients with advanced pancreatic or biliary tract cancer (aPBC) receiving beyond first-line chemotherapy. Supportive Care in Cancer. 2024. doi:10.1007/s00520-024-08650-9

BibTeX
@article{DeLazzari2024,
  author = {De Lazzari, Nico and Götte, Miriam and Kasper, Stefan and Meier, Eileen and Schuler, Martin and Pogorzelski, Michael and Siveke, Jens T and Tewes, Mitra},
  title = {P-move: a randomized control trial of exercise in patients with advanced pancreatic or biliary tract cancer (aPBC) receiving beyond first-line chemotherapy},
  journal = {Supportive Care in Cancer},
  year = {2024},
  doi = {10.1007/s00520-024-08650-9}
}
Kostenlos starten →